ARTL

Artelo Biosciences, Inc. - Common Stock (ARTL)

About Artelo Biosciences, Inc. - Common Stock (ARTL)

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Details

Daily high

$4.94

Daily low

$4.24

Price at open

$4.85

52 Week High

$85.80

52 Week Low

$3.15

Market cap

4.1M

Dividend yield

0.00%

Volume

2.5M

Avg. volume

3.7M

P/E ratio

-.12

Artelo Biosciences, Inc. - Common Stock News